HR+/HER2− BC cell map

309 programs (172 active, 137 discontinued) placed at the step where they act.

Cell View

Active programDiscontinued (color = drug type)Inferred placementPossibly inactiveStepNo program yetOveractive / reducedFixed by selected drugRouteDrivesInhibits

← Scroll to see the whole cell →

Aromatase (androgen to estrogen) ✓ Estrogen (estradiol) ✓ Estrogen receptor α (ERα, ESR1) ↑ ✓ ESR1-mutant ERα (ligand-independent) ↑ ✓ ER coactivators (FOXA1, GATA3) ✓ KAT6A/B histone acetyltransferase ↑ ✓ Histone deacetylases and BET readers ✓ Androgen receptor ✓ ER-target genes (cyclin D1, MYC, BCL2) ↑ ✓ CDK4/6–cyclin D ↑ ✓ CDK7 kinase ✓ RB phosphorylation and E2F release ✓ CDK2–cyclin E ✓ S-phase entry and proliferation ↑ ✓ PARP / BRCA DNA repair ✓ DNA methylation (DNMT1) ✓ Endogenous retrovirus RNA (dsRNA) ✓ dsRNA sensors (MDA5, RIG-I, TLR3) ✓ Type I interferon response ✓ MHC class I antigen presentation ↓ ✓ PD-L1 (tumor cell) ✓ CD47 ("do not eat me" signal) ↑ ✓ GRPR (radioligand target) ↑ ✓ TROP2 (ADC target) ↑ ✓ HER2 / HER3 (ERBB) receptors ✓ FGFR1/2 (FGF receptors) ↑ ✓ IGF1R (IGF-1 receptor) ✓ Other ADC and radioligand targets ✓ SRC kinase ✓ PI3Kα (PIK3CA) ↑ ✓ AKT (protein kinase B) ↑ ✓ mTOR (mTORC1) ✓ RAS–MAPK (ERK1/2) ↑ ✓ RSK (p90 ribosomal S6 kinase) ↑ ✓ BCL2 (apoptosis block) ✓ CD8 T cell (recognizes MHC-I) ↓ ✓ PD-1 (T cell) ✓ LAG-3 (T cell) ↑ ✓ TIGIT and other T-cell checkpoints ✓ Antigen-presenting (dendritic) cell ✓ Tumor-associated macrophage / myeloid cell ↑ ✓ SIRPα (myeloid cell) ✓ Blood vessel (VEGF, angiogenesis) ✓ Undisclosed (16) Whole-organ / systemic (13) Estrogen–ER signaling (whole pathway) CDK4/6–RB–E2F cell cycle (whole pathway) T-cell recognition and checkpoints (whole pathway)

Pathway diagram is a simplified schematic, not to scale.

How to read this

  • Each dot is an active program, placed at the step where its drug acts. Each rounded square is a discontinued program. Color shows the drug type.
  • A hollow dot means the placement is inferred; a dashed ring means the program is possibly inactive.
  • Click a dot, square, step, arrow or bubble to see its details here. Selecting a program highlights its step, turns the steps it is expected to normalize green (✓) and lights up the links between them.
  • ↑ and ↓ mark steps that are overactive or reduced in HR+/HER2− BC. "Healthy cell" hides them.
  • Filters dim programs; they never remove them. Programs in the dashed bubbles have no single step: their mechanism is undisclosed, or they act on the whole body.

Other discontinued programs (no step on this map) (20)